ATP Cancer Research Results

ATP, Adenosine triphosphate: Click to Expand ⟱
Source:
Type:
Adenosine triphosphate (ATP) is the source of energy for use and storage at the cellular level.
Cellular ATP levels are critical for cell survival, and several reports have shown that reductions in cellular ATP levels can lead to apoptosis and other types of cell death in cancer cells, depending on the level of depletion.
Adenosine triphosphate (ATP) is one of the main biochemical components of the tumor microenvironment (TME), where it can promote tumor progression or tumor suppression depending on its concentration and on the specific ecto-nucleotidases and receptors expressed by immune and cancer cells.

Cancer cells, unlike normal cells, derive as much as 60% of their ATP from glycolysis via the “Warburg effect”, and the remaining 40% is derived from mitochondrial oxidative phosphorylation.


Scientific Papers found: Click to Expand⟱
8327- LIN,    Recent updates on bioactive properties of linalool
- Review, Var, NA
*AntiCan↑, *AntiBio↑, *neuroP↑, *Stress↓, *hepatoP↑, *RenoP↑, *ROS↓, ROS↑, *Inflam↓, *toxicity↓, TumCP↓, TumCCA↑, mtDam↑, MMP↓, compI↓, compII↓, ETC↓, ATP↓, angioG↓, ChemoSen↑, *GSH↑, *MDA↓, *lipid-P↓, *NRF2↑, *HO-1↑, *ALAT↓, *AST↓, chemoP↑,
8326- LIN,    Linalool in cancer pharmacology: pharmacokinetic limitations and preclinical cytotoxic evidence for translational development
- Review, Var, NA
Dose↝, *BioAv↓, BioAv↝, tumCV↓, compI↓, compII↓, ROS↑, ATP↓, GSH↓, mtDam↑, Casp↑, NF-kB↓, MMP↓, TumCCA↑, PI3K↓, Akt↓, angioG↓, CD31/PECAM-1↓, Ki-67↓,
8386- LT,    Luteolin induces apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia cell by regulating the PI3K/AKT signaling pathway
- in-vitro, ALL, SUP-B15
tumCV↓, ROS↑, MMP↓, ATP↓, p‑PI3K↓, p‑Akt↓, p‑STAT3↓, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑Casp9↑, TumCP↓, eff↓, ChemoSen↑, FAK↓, Synergy↑, BioAv↓, BioAv↑,
2913- LT,    Luteolin induces apoptosis by impairing mitochondrial function and targeting the intrinsic apoptosis pathway in gastric cancer cells
- in-vitro, GC, HGC27 - in-vitro, BC, MCF7 - in-vitro, GC, MKN45
TumCP↓, MMP↓, Apoptosis↑, ROS↑, SOD↓, ATP↓, Bax:Bcl2↑, TumCCA↑,
4292- LT,    Luteolin for neurodegenerative diseases: a review
- Review, AD, NA - Review, Park, NA - Review, MS, NA - Review, Stroke, NA
*Inflam↓, *antiOx↑, *neuroP↑, *BioAv↝, *BBB↑, *TNF-α↓, *IL1β↓, *IL6↓, *IL8↓, *IL33↓, *NF-kB↓, *BACE/β-secretase↓, *ROS↓, *SOD↑, *HO-1↑, *NRF2↑, *Casp3↓, *Casp9↑, *Bax:Bcl2↓, *UPR↑, *GRP78/BiP↑, *Aβ↓, *GSK‐3β↓, *tau↓, *CREB↑, *ATP↑, *cognitive↑, *BloodF↑, *BDNF↑, *TrkB↑, *memory↑, *PPARγ↑, *Synergy↑,
8417- Lyco,    Lycopene alleviates age-related cognitive deficit via activating liver-brain fibroblast growth factor-21 signalling
- in-vivo, AD, NA
*cognitive↑, *FGF21↑, *ATP↑,
8734- M-Blu,    From Mitochondrial Function to Neuroprotection – An Emerging Role for Methylene Blue
- Review, AD, NA
*ETC↑, *compIV↑, *ROS↓, *NeuroI↓, *neuroP↑, *Stroke↓, *cognitive↑, *BBB↑, *BloodF↑, *NOS2↓, *lipid-P↓, *Inflam↓, *Synergy↑, *OCR↑, *compIV↑, *ATP↑, *Casp↓, *MMP↑, *tau↓,
8733- M-Blu,    Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
- Review, AD, NA - Review, Stroke, NA
*ETC↑, *ROS↓, *Inflam↓, *memfluid↑, *BloodF↑, *BBB↑, *OCR↑, *ATP↑, *BioAv↑, *Aβ↓, *compIV↑, *Stroke↓, *compI↑, *compII↑, *compIII↑, *GlucoseCon↑, *neuroG↑,
2542- M-Blu,    In Vitro Methylene Blue and Carboplatin Combination Triggers Ovarian Cancer Cells Death
- in-vitro, Ovarian, OV1369 - in-vitro, Ovarian, OV1946 - in-vitro, Nor, ARPE-19
BioAv↝, TumCP↓, GlutaM↓, Warburg↓, OCR↑, Glycolysis↓, ATP↓, BioAv↝, ROS↑,
8559- Matr,    Matrine induces toxicity in mouse liver cells through an ROS-dependent mechanism
- vitro+vivo, Nor, NA
*Dose↝, *toxicity↑, *Casp3↑, *Casp9↑, *ROS↑, *MMP↓, *ATP↓, *eff↓,
8526- Matr,    A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine
- Review, Nor, NA
*AntiCan↑, *Inflam↓, *antiOx↑, *AntiViral↑, *Bacteria↓, *antiAll↑, *Analgesic↑, *hepatoP↑, *cardioP↑, *neuroP↑, *toxicity↝, p38↓, IL6↓, JAK2↓, STAT3↓, Casp↑, PI3K↓, Akt↓, mTOR↓, Beclin-1/ATG6↑, PCNA↓, Bcl-2↓, XIAP↑, VEGF↓, NF-kB↓, MMP2↓, MMP9↓, P-gp/ABCB1↓, survivin↓, OCT4↓, SOX2↓, p62↓, *TNF-α↓, *IL6↓, *HMGB1↓, *AntiArt↑, *NF-kB↓, *IL6↓, *IL8↓, *IL1β↓, *IL17↓, *TNF-α↓, *ROS↓, *NRF2?, *AST↓, *ALAT↓, *TGF-β↓, *α-SMA↓, *JAK2↑, *STAT3↑, *BioAv↝, *Half-Life↝, ChemoSen↑, ATP↓, ROS↑,
2643- MCT,    Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism
- Review, Nor, NA
*Akt↑, *AMPK↓, *TGF-β↓, eff↑, *BioEnh↑, *ATP↑, *PGC-1α↑, *p‑mTOR↑, *SMAD3↓,
8714- MeJa,    Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
- in-vitro, Colon, CT26
HK2↓, eff↝, mtDam↑, ATP↓, other↝,
8706- MET,    Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients
- Review, Var, NA
OXPHOS↓, compI↓, ATP↝,
2457- MET,    Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
- in-vitro, Lung, Calu-1
HK1↓, HK2↓, GlucoseCon↓, MMP↓, ATP↓,
994- MET,    Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy
- in-vitro, Var, NA
Glycolysis↓, HK2↓, ATP↓, AMPK↑, P53↑, Warburg↓, Apoptosis↑,
5800- MET,    Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect
- Review, Var, NA
ChemoSen↑, RadioS↑, Imm↑, *AntiDiabetic↑, *AMPK↑, TumCP↓, hepatoP↑, ATP↓, AMP↑, glucoNG↓, ROS↑, compI↓, DNAdam↑, CSCs↓, NP/CIPN↓, chemoP↑, toxicity↓, Trx↓, Synergy↑, cycD1/CCND1↓, CDK4↓, CDK6↓, cycE/CCNE↓, CDK2↓,
5241- MF,    A review on the use of magnetic fields and ultrasound for non-invasive cancer treatment
- Review, Var, NA
other↑, BloodF↑, Glycolysis↓, ATP↓, VEGF↓, ROS↑, P-gp/ABCB1↓, Apoptosis↑, selectivity↑, Ca+2↑, Catalase↑,
2247- MF,    Effects of Pulsed Electromagnetic Field Treatment on Skeletal Muscle Tissue Recovery in a Rat Model of Collagenase-Induced Tendinopathy: Results from a Proteome Analysis
- in-vivo, Nor, NA
*Glycolysis↓, *LDHB↑, *NAD↑, *ATP↑, *antiOx↑, *ROS↑, *YAP/TEAD↑, *PGC-1α↑, *TCA↑, *FAO↑, *OXPHOS↑,
2242- MF,    Electromagnetic stimulation increases mitochondrial function in osteogenic cells and promotes bone fracture repair
- in-vitro, Nor, NA
*MMP↑, *Diff↑, *OXPHOS↑, *BMD↑, ATP∅,
3477- MF,    Electromagnetic fields regulate calcium-mediated cell fate of stem cells: osteogenesis, chondrogenesis and apoptosis
- Review, Var, NA
*Ca+2↑, *VEGF↑, *angioG↑, Ca+2↑, ROS↑, Necroptosis↑, TumCCA↑, Apoptosis↑, *ATP↑, *FAK↑, *Wnt↑, *β-catenin/ZEB1↑, *ROS↑, p38↑, MAPK↑, β-catenin/ZEB1↓, CSCs↓, TumCP↓, ROS↑, RadioS↑, Ca+2↑, eff↓, NO↑,
531- MF,    6-mT 0-120-Hz magnetic fields differentially affect cellular ATP levels
- in-vitro, Cerv, HeLa - in-vitro, CRC, HCT116 - in-vitro, BC, MCF7 - in-vitro, Lung, A549 - in-vitro, Nor, RPE-1 - in-vitro, Nor, GP-293
ATP⇅,
537- MF,  immuno,    Integrating electromagnetic cancer stress with immunotherapy: a therapeutic paradigm
- Review, Var, NA
Apoptosis↑, ROS↑, TumAuto↑, Ca+2↑, ATP↓, eff↑, eff↑,
538- MF,    The extremely low frequency electromagnetic stimulation selective for cancer cells elicits growth arrest through a metabolic shift
- in-vitro, BC, MDA-MB-231 - in-vitro, Melanoma, MSTO-211H
TumCG↓, Ca+2↑, COX2/PTGS2↓, ATP↑, MMP↑, ROS↑, OXPHOS↑, mitResp↑,
493- MF,    Extremely low-frequency electromagnetic field induces acetylation of heat shock proteins and enhances protein folding
- in-vitro, NA, HEK293 - in-vitro, Liver, AML12
ATP↑, HSP70/HSPA5↓, HSP90↓,
4355- MF,    Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism
- in-vitro, Nor, C2C12
*mt-OCR↑, *mt-ROS↑, *ECAR↑, *Dose↝, *Ca+2↑, *ATP↑, *other↑, *eff↓, *eff↝,
9267- MFrot,    EXTH-12. Oncomagnetic Monotherapy Mediated Anti-Tumor Immune Response in Glioblastoma
- Review, GBM, NA
TumCP↓, tumCV↓, ROS↑, MMP↓, ATP↓, DNAdam↑, TumCCA↑, TumCG↓, OS↑, Imm↑, CD4+↑, CD8+↑,
773- Mg,    Methyl Jasmonate-induced Increase in Intracellular Magnesium Promotes Apoptosis in Breast Cancer Cells
- in-vitro, BC, MCF7
TRPM7↓, ROS↑, ER Stress↑, MAPK↑, ATP↓,
8736- MGO,    Selective inhibition of mitochondrial respiration and glycolysis in human leukaemic leucocytes by methylglyoxal
- in-vitro, AML, NA
mitResp↓, selectivity↑, lactateProd↓, ATP↓, Glycolysis↓, compI↓,
1891- MGO,    Methylglyoxal induces mitochondria-dependent apoptosis in sarcoma
- in-vitro, SCC, NA
NADH↓, MMP↓, Cyt‑c↑, selectivity↑, Apoptosis↑, ROS↑, ATP↓,
1778- MLT,    Melatonin: a well-documented antioxidant with conditional pro-oxidant actions
- Review, Var, NA - Review, AD, NA
*ROS↓, *antiOx↓, ROS↑, selectivity↑, Dose↑, *mitResp↑, *ATP↑, *ROS↓, eff↑, ROS↑, Dose↑, *toxicity∅, ROS↑, eff↓, ROS↝, Dose↑, other↑,
1780- MLT,    Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing
- Review, Var, NA
*antiOx↑, *toxicity↓, ChemoSen↑, *eff↑, *mitResp↑, *ATP↑, *ROS↓, *CardioT↓, *GSH↑, *NOS2↓, *lipid-P↓, eff↑, *HO-1↑, *NRF2↑, *NF-kB↑, TumCP↓, eff↑, neuroP↑,
6419- MLT,    The potential influence of melatonin on mitochondrial quality control: a review
- Review, Nor, NA
*mt-ACC⇅, *PKM1↑, *PKM2↑, *Glycolysis↝, *PDKs↑, *FAO↑, *ETC↑, *OXPHOS↑, *ATP↑, Glycolysis↓, OXPHOS↑, *Ca+2↓, *ROS↓, *antiOx↑, *SOD2↑, *GPx↑, *Catalase↑, *MFN1↑, *MFN2↑, *OPA1↑, *YAP/TEAD↑, *Hippo↑, *SIRT1↑, *PGC-1α↑, *DRP1/DNM1L↓,
8663- MLT,    Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect
- vitro+vivo, RCC, 786-O
TumCG↓, ROS↑, TAC↓, TCA↑, Glycolysis↓, OCR↑, ATP↑, MMP↑, p‑Akt↓, p‑mTOR↓, p‑P70S6K↓, Hif1a↓, VEGFR1↓, eff↓, Synergy↑, Warburg↓, TumCP↓, SOD↓, GSH↓, Catalase↓, GPx↑, Warburg↓, OXPHOS↑, Hif1a↓, VEGF↓, Ki-67↓, Akt↓, mTOR↓,
995- MLT,    Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma
- vitro+vivo, GBM, NA
LDHA↓, MCT4↓, lactateProd↓, i-pH↓, ROS↑, ATP↓, TumCD↑, TumCCA↑, PDH↓, Glycolysis↓, GlucoseCon↓, TumCG↓,
8915- MO,    Therapeutic Potential of Moringa oleifera in Alzheimer’s Disease: A Review of Neuroprotective Mechanisms
- Review, AD, NA
*Ingr↝, *antiOx↑, *Inflam↓, *NRF2↑, *ARE↑, *AChE↓, *Aβ42↓, *cognitive↑, *BACE/β-secretase↓, *neuroP↑, *PI3K↑, *Akt↑, *mTOR↑, *Learn↑, *memory↑, *ATP↑, *SOD↑, *Catalase↑, *p‑tau↓,
8863- MOR,    Morin Inhibits Proliferation of SW480 Colorectal Cancer Cells by Inducing Apoptosis Mediated by Reactive Oxygen Species Formation and Uncoupling of Warburg Effect
- in-vitro, Colon, SW48
TumCP↓, Apoptosis↑, ROS↑, MMP↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp8↑, cl‑Casp9↑, BAX↑, Bcl-2↓, ATP↓, GlucoseCon↓, GLUT1↓, Warburg↓, Dose↝, Catalase↓, GSH↓, ADP:ATP↑, AMP↑,
8936- MushCha,    Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis
- vitro+vivo, Lung, LLC1
AMPK↑, tumCV↓, Apoptosis↑, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, MMP↓, OXPHOS↓, Glycolysis↓, Dose?, MPT↑, ATP↓,
2452- PA,    Targeting Pyruvate Kinase M2 and Hexokinase II, Pachymic Acid Impairs Glucose Metabolism and Induces Mitochondrial Apoptosis
- in-vitro, BC, SkBr3
HK2↓, GlucoseCon↓, lactateProd↓, mtDam↑, ATP↓, ROS↑, PKM2↑,
2451- PA,    The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors
- Review, Var, NA
HK2↓, ATP↓, ROS↑,
1672- PBG,    The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers
- Review, BC, NA
ChemoSen↓, RadioS↑, Inflam↓, AntiCan↑, Dose∅, mtDam↑, Apoptosis?, OCR↓, ATP↓, ROS↑, ROS↑, LDH↓, TP53↓, Casp3↓, BAX↓, P21↓, ROS↑, eNOS↑, iNOS↑, Synergy↑, hTERT/TERT↓, cycD1/CCND1↓, Synergy↑, Synergy↑, eff↑, eff↑, STAT3↓, TIMP1↓, IL4↓, IL10↓, OS↑, Dose∅, ER Stress↑, ROS↑, NF-kB↓, p65↓, MMP↓, TumAuto↑, LC3II↑, p62↓, TLR4↓, mtDam↑, LDH↓, ROS↑, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDH↓, IL10↓, HDAC8↓, eff↑, eff↑, P21↑,
2430- PBG,    The cytotoxic effects of propolis on breast cancer cells involve PI3K/Akt and ERK1/2 pathways, mitochondrial membrane potential, and reactive oxygen species generation
- in-vitro, BC, MDA-MB-231
TumCP↓, TP53↓, Casp3↓, BAX↓, P21↓, ROS↑, eff↓, MMP↓, LDH↑, ATP↓, Ca+2↑,
4946- PEITC,    Phenethyl Isothiocyanate Inhibits Oxidative Phosphorylation to Trigger Reactive Oxygen Species-mediated Death of Human Prostate Cancer Cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3
Apoptosis↑, TumAuto↑, ROS↑, OXPHOS↓, ATP↓, selectivity↑, ETC↓, eff↓, eff↓, BAX↑,
4922- PEITC,    Phenethyl Isothiocyanate: A comprehensive review of anti-cancer mechanisms
- Review, Var, NA
Risk↓, AntiCan↑, TumCP↓, TumMeta↓, ChemoSen↑, *BioAv↑, *other↝, *Dose↝, Dose↓, *BioAv↑, *Dose↝, *Half-Life↝, *toxicity↝, GSH↓, ROS↑, CYP1A1↑, CYP1A2↑, P450↓, CYP2E1↑, CYP3A4↓, CYP2A3/CYP2A6↓, *ROS↓, *GPx1↑, *SOD1↑, *SOD2↑, Akt↓, EGFR↓, HER2/EBBR2↓, P53↑, Telomerase↓, selectivity↑, MMP↓, Cyt‑c↑, Apoptosis↑, DR4↑, Fas↑, XIAP↓, survivin↓, TumAuto↑, Hif1a↓, angioG↓, MMPs↓, ERK↓, NF-kB↓, EMT↓, TumCI↓, TumCMig↓, Glycolysis↓, ATP↓, selectivity↑, *antiOx↑, Dose↝, other↝, OCR↓, GSH↓, ITGB1↓, ITGB6↓, ChemoSen↑,
2409- PTS,    Pterostilbene Induces Pyroptosis in Breast Cancer Cells through Pyruvate Kinase 2/Caspase-8/Gasdermin C Signaling Pathway
- in-vitro, BC, EMT6 - in-vitro, BC, 4T1 - in-vitro, Nor, HC11
Pyro↑, Glycolysis↓, *toxicity∅, selectivity↑, GSDMC↑, PKM2↓, PKM1↑, GlucoseCon↓, lactateProd↓, ATP↓, TumCG↓,
3350- QC,    Quercetin and the mitochondria: A mechanistic view
- Review, Var, NA
*antiOx↑, *Inflam↓, *NRF2↑, ROS⇅, *NRF2↑, *HO-1↑, *PPARα↑, *PGC-1α↑, *SIRT1↑, *ATP↑, ATP↓, ERK↓, cl‑PARP↑, Casp9↑, Casp8↑, BAX↑, MMP↓, Cyt‑c↑, Casp3↑, HSP27↓, HSP72↓, RAS↓, Raf↓,
3336- QC,    Neuroprotective Effects of Quercetin in Alzheimer’s Disease
- Review, AD, NA
*neuroP↑, *lipid-P↓, *antiOx↑, *Aβ↓, *Inflam↓, *BBB↝, *NF-kB↓, *iNOS↓, *memory↑, *cognitive↑, *AChE↓, *MMP↑, *ROS↓, *ATP↑, *AMPK↑, *NADPH↓, *p‑tau↓,
1201- QC,    Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1
- in-vivo, BC, NA
mitResp↓, Glycolysis↓, ATP↓, ROS↑, GSH↓, TumMeta↓, Apoptosis↑, FAO↓,
39- QC,    A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells
- Analysis, Var, NA
ROS↑, GSH↓, IL6↓, COX2/PTGS2↓, IL8↓, iNOS↓, TNF-α↓, MAPK↑, ERK↑, SOD↑, ATP↓, Casp↑, PI3K/Akt↓, mTOR↓, NOTCH1↓, Bcl-2↓, BAX↑, IFN-γ↓, TumCP↓, TumCCA↑, Akt↓, P70S6K↓, *Keap1↓, *GPx↑, *Catalase↑, *HO-1↑, *NRF2↑, NRF2↑, Synergy↑, HIF-1↓,
889- QC,    The multifaceted role of quercetin derived from its mitochondrial mechanism
- vitro+vivo, Var, NA
MMP↓, ATP↝, OXPHOS↝, ROS↑,

Showing Research Papers: 151 to 200 of 257
Prev Page 4 of 6 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 257

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   ARE↓, 1,   Catalase↓, 3,   Catalase↑, 2,   Fenton↑, 2,   GPx↓, 2,   GPx↑, 1,   GPx4↓, 4,   GSH↓, 24,   GSH↑, 1,   GSH/GSSG↓, 2,   GSTs↑, 1,   H2O2↑, 2,   HO-1↓, 1,   HO-1↑, 3,   Iron↑, 4,   lipid-P↓, 1,   lipid-P↑, 8,   MDA↑, 5,   i-MDA↑, 1,   NADH↓, 2,   NQO1↑, 1,   NRF2↓, 3,   NRF2↑, 6,   ROS↓, 7,   ROS↑, 128,   ROS⇅, 1,   ROS↝, 1,   mt-ROS↑, 4,   SOD↓, 4,   SOD↑, 2,   mt-SOD↑, 1,   SOD1↓, 1,   SOD2↑, 1,   TAC↓, 1,   Thiols↓, 1,   Trx↓, 1,   Trx1↓, 2,   TrxR↓, 3,   TrxR1↓, 1,   xCT/SLC7A11↓, 4,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Zn2+↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC2↓, 1,   CDC25↓, 1,   compI↓, 11,   compII↓, 4,   compIII↓, 2,   compIII↑, 1,   compIV↓, 1,   compV↓, 1,   ETC↓, 6,   ETC↑, 1,   Insulin↓, 1,   MCU↓, 1,   mitResp↓, 14,   mitResp↑, 2,   mtDam↑, 23,   OCR↓, 14,   OCR↑, 7,   OXPHOS↓, 18,   OXPHOS↑, 7,   OXPHOS↝, 2,   mt-OXPHOS↓, 4,   PDH↓, 5,   PDH↑, 2,   PGC-1α↑, 1,   VDAC1↓, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

3MST/MPST↑, 1,   ACLY↓, 1,   ACLY↑, 1,   adiP↑, 1,   ALAT↓, 2,   ALDOA↓, 1,   ALDOB↑, 1,   AminoA↓, 1,   AMP↑, 3,   AMPK↑, 15,   p‑AMPK↑, 3,   ATP↓, 170,   ATP↑, 7,   ATP⇅, 1,   ATP↝, 3,   ATP∅, 2,   e-ATP↑, 1,   i-ATP↓, 3,   i-ATP↑, 1,   mt-ATP↓, 2,   ATP:AMP↓, 1,   BHB↑, 1,   CAIX/CA9↓, 1,   CBS↑, 1,   ECAR↓, 8,   ECAR↑, 1,   ENO1↓, 2,   ENO3↑, 1,   FAO↓, 2,   FAO↑, 1,   FASN↓, 4,   FBP1↑, 1,   FBPase↑, 1,   G6PD↓, 1,   GAPDH↓, 4,   GLO-I↓, 1,   GLS↓, 1,   glucoNG↓, 2,   glucoNG↑, 1,   glucose↓, 2,   GlucoseCon↓, 31,   GlucoseCon↑, 1,   GlutaM↓, 2,   GlutMet↓, 1,   glyC↓, 1,   Glycolysis↓, 69,   Glycolysis↑, 1,   GSK‐3β↓, 1,   GSK‐3β↑, 2,   GSK‐3β↝, 1,   HK1↓, 3,   HK2?, 1,   HK2↓, 41,   HK3↑, 1,   HMG-CoA↓, 2,   HMGCS2↑, 1,   lactateProd↓, 34,   lactateProd↑, 2,   e-lactateProd↓, 1,   LDHA↓, 17,   lipidLev↓, 1,   lipoGen↓, 3,   MCT4↓, 1,   NAD↓, 3,   NADPH↓, 4,   PCK1↑, 1,   PDK1 / PDPK1↓, 11,   PDK3↑, 1,   PFK↓, 5,   PFK1↓, 4,   PFK2↓, 1,   PFKP↓, 1,   PGK1↓, 2,   PGK2↑, 1,   PGM1↓, 1,   PGM1↑, 1,   PGM3↑, 1,   PKLR↑, 1,   PKM1↑, 2,   PKM2↓, 21,   PKM2↑, 1,   PPP↓, 2,   Pyruv↓, 2,   Pyruv↑, 1,   p‑S6↓, 1,   SCD1↓, 2,   SIRT1↓, 1,   SIRT1↑, 2,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   TCA↓, 3,   TCA↑, 3,   Warburg↓, 17,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 6,   APAF1↑, 1,   Apoptosis?, 3,   Apoptosis↑, 79,   mt-Apoptosis↑, 2,   BAD↑, 2,   Bak↓, 1,   Bak↑, 1,   BAX↓, 2,   BAX↑, 18,   Bax:Bcl2↑, 6,   Bcl-2↓, 24,   Bcl-xL↓, 3,   BID↑, 1,   BNIP3?, 1,   BNIP3↝, 1,   Casp↑, 15,   Casp∅, 1,   Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 3,   Casp3↑, 32,   cl‑Casp3↑, 8,   Casp7↑, 4,   Casp8↑, 5,   cl‑Casp8↑, 1,   Casp9↑, 14,   cl‑Casp9↑, 3,   cFLIP↓, 1,   Cupro↑, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 25,   DR5↑, 1,   FADD↑, 1,   Fas↑, 5,   FasL↑, 1,   Ferroptosis↓, 1,   Ferroptosis↑, 7,   GSDMC↑, 1,   GSDME-N↑, 1,   IAP1↓, 1,   IAP2/BIRC3↓, 1,   ICD↑, 5,   iNOS↓, 1,   iNOS↑, 1,   Mcl-1↓, 7,   MDM2↓, 2,   MLKL↑, 2,   MOMP↑, 4,   Necroptosis↑, 3,   necrosis↑, 5,   NOXA↑, 1,   p38↓, 2,   p38↑, 6,   PUMA↑, 1,   Pyro↑, 2,   RIP3↑, 1,   p‑RIP3↑, 2,   survivin↓, 11,   TumCD↑, 11,   XIAP↓, 4,   XIAP↑, 1,   YAP/TEAD↓, 3,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 44,   Akt↑, 1,   p‑Akt↓, 7,   p‑Akt↑, 1,   AKT1↓, 2,   AMPKα↑, 1,   CK2↓, 1,   p‑cMET↑, 1,   EGFR↓, 9,   EGFR↑, 1,   ERK↓, 10,   ERK↑, 3,   p‑ERK↓, 3,   FOXD3↑, 1,   HER2/EBBR2↓, 5,   Hippo↓, 1,   IGF-1R↓, 2,   JAK↓, 2,   JAK2↓, 3,   JNK↓, 2,   JNK↑, 4,   p‑JNK↓, 1,   p‑JNK↑, 1,   MAPK↓, 5,   MAPK↑, 4,   p‑MAPK↓, 1,   MEK↓, 1,   mTOR↓, 27,   p‑mTOR↓, 3,   mTORC2↓, 1,   P70S6K↓, 3,   p‑P70S6K↓, 2,   PHKG1↑, 1,   PI3K↓, 23,   PI3K↑, 1,   p‑PI3K↓, 2,   PI3K/Akt↓, 2,   PKA↓, 2,   PKCδ↓, 3,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↑, 3,   Raf↓, 2,   RAS↓, 1,   RIP1↓, 1,   p‑S6K↓, 2,   Sp1/3/4↓, 4,   STAT↓, 1,   STAT3↓, 13,   STAT3↝, 1,   p‑STAT3↓, 2,   STAT5↓, 1,   p‑STAT5↓, 1,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↓, 1,   ATF4↑, 1,   cJun↓, 1,   cJun↑, 1,   cMyc↓, 9,   DNMT1↓, 1,   DNMTs↓, 1,   EZH2↓, 1,   FOXO3↑, 1,   FOXO4↓, 1,   H3↓, 1,   ac‑H3↑, 1,   H3K9↓, 1,   ac‑H4↑, 1,   HATs↓, 1,   HATs↑, 1,   HDAC↓, 7,   HDAC2↓, 1,   HDAC3↓, 1,   HDAC4↓, 1,   HDAC8↓, 2,   HMTs↓, 2,   miR-124-3p↓, 1,   miR-203↑, 1,   miR-339-5p↑, 1,   miR-34a↓, 1,   miR-34a↑, 1,   miR-375↑, 1,   Myc↓, 1,   n-MYC↓, 1,   OCT4↓, 1,   other↓, 2,   other↑, 4,   other↝, 7,   OV6↓, 1,   SOX2↓, 3,   SOX9↓, 1,   SUV39H↓, 1,   TFE3↑, 2,   tumCV?, 1,   tumCV↓, 17,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 4,   CRT↑, 1,   i-CRT↓, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 1,   ER Stress↑, 17,   HSP27↓, 2,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 1,   HSP72↓, 1,   HSP90↓, 2,   HSP90↑, 1,   NQO2↑, 1,   PERK↑, 2,   UPR↑, 2,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 2,   ATG5↑, 2,   ATG5↝, 1,   ATG7↑, 1,   autoF↓, 2,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 5,   Beclin-1/ATG6↝, 1,   p‑Beclin-1/ATG6↑, 1,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 4,   LC3B-II↑, 1,   LC3II↑, 3,   lysoMP↑, 1,   lysosome↓, 1,   lysosome↝, 1,   MitoP↑, 1,   p62↓, 5,   p62↑, 2,   RUBCN↓, 1,   TumAuto↑, 27,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 2,   p‑ATM↑, 2,   DNAdam↑, 22,   mt-DNAdam↑, 1,   DNArepair↑, 1,   hTERT/TERT↓, 3,   P53↓, 2,   P53↑, 16,   P53↝, 1,   p‑P53↑, 1,   p53 Wildtype∅, 1,   PARP↓, 1,   PARP↑, 5,   cl‑PARP↓, 1,   cl‑PARP↑, 11,   cl‑PARP1↑, 1,   PCNA↓, 7,   POLD1↓, 1,   Telomerase↓, 3,   TOP1?, 1,   TOP1↓, 2,   TP53↓, 2,   TP53↑, 1,   TRF2↓, 1,   γH2AX↑, 5,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 3,   CDK2↓, 6,   CDK4↓, 8,   CDK6↓, 3,   CDK6↑, 1,   Cyc↓, 1,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 4,   cycD1/CCND1↓, 12,   cycD1/CCND1↑, 2,   cycE/CCNE↓, 3,   cycE/CCNE↑, 1,   Ki-67↓, 8,   mitA↓, 1,   mitA↑, 1,   P21↓, 3,   P21↑, 9,   p27/CDKN1B↑, 6,   TumCCA↑, 48,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   p‑4E-BP1↓, 1,   ALDH↓, 4,   CD133↓, 2,   CD24↓, 2,   CSCs?, 1,   CSCs↓, 19,   CSCs↑, 1,   CSCsMark↓, 1,   Diff↓, 1,   FGF↓, 1,   Gli1↓, 2,   HMGCR↓, 1,   IGF-1↓, 5,   IGFBP1↑, 1,   IGFBP3↑, 1,   Ki-67↓, 8,   mTORC1↓, 2,   p‑mTORC1↓, 1,   Nanog↓, 1,   Nestin↓, 1,   NOTCH↓, 4,   NOTCH1↓, 2,   NOTCH1↑, 1,   PTCH1↓, 1,   Shh↓, 1,   Smo↓, 2,   TumCG↓, 41,   TumCG↑, 2,   TumCP↓, 57,   TumCP↑, 2,   Wnt↓, 9,   Wnt/(β-catenin)↓, 1,   Zn2+↑, 1,  

Migration(tgid=13) ⓘ

AP-1↓, 1,   ATPase↓, 1,   BACH1↓, 1,   CA↓, 1,   Ca+2↓, 1,   Ca+2↑, 22,   Ca+2↝, 1,   i-Ca+2↑, 1,   Chl↑, 1,   E-cadherin↑, 8,   EMT↓, 17,   EpCAM↓, 1,   FAK↓, 3,   p‑FAK↓, 2,   Fibronectin↓, 1,   Furin↓, 1,   GLI2↓, 1,   ITGB1↓, 1,   ITGB6↓, 1,   LAMs↓, 1,   MALAT1↓, 1,   MET↓, 1,   MMP-10↓, 1,   MMP2↓, 11,   MMP3↓, 2,   MMP9↓, 13,   MMP9↑, 1,   MMPs↓, 5,   MUC4↓, 1,   N-cadherin↓, 2,   PAK1↓, 2,   PAK1↑, 1,   PDGF↓, 1,   Rho↓, 3,   ROCK1↓, 1,   Slug↓, 3,   SMAD2↓, 1,   SMAD3↓, 1,   Snail↓, 6,   SPARC↑, 2,   STAC2↓, 1,   TGF-β↓, 5,   TIMP1↓, 1,   TIMP1↑, 2,   TIMP2↑, 1,   TRIB3↑, 1,   TSC1↑, 1,   TumCA↓, 1,   TumCA↑, 1,   TumCI↓, 21,   TumCI↑, 1,   TumCMig↓, 20,   TumCMig↑, 1,   TumMeta↓, 16,   TumMeta↑, 2,   TumPF↓, 2,   Twist↓, 1,   uPA↓, 3,   uPAR↓, 1,   Vim?, 1,   Vim↓, 2,   Zeb1↓, 3,   β-catenin/ZEB1↓, 5,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 17,   angioG↑, 1,   CD31/PECAM-1↓, 2,   eNOS↓, 1,   eNOS↑, 1,   HIF-1↓, 4,   Hif1a↓, 29,   Hypoxia↓, 1,   NO↑, 4,   VEGF↓, 21,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   CellMemb↑, 1,   CTR1↑, 1,   CX43/GJA1↓, 1,   EPR↑, 1,   GLUT1↓, 22,   GLUT2↓, 1,   GLUT4↓, 5,   MMP↓, 62,   MMP↑, 3,   MPT↑, 4,   NHE1↓, 1,   SVCT-2∅, 1,   TRPM7↓, 1,   TRPV1↑, 1,   TRPV2↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD25+↑, 1,   CD4+↑, 2,   CD44↓, 3,   CD47↓, 1,   CD8+↑, 7,   COX2/PTGS2↓, 13,   COX2/PTGS2↑, 1,   CXCR4↓, 1,   DCells↑, 1,   DR4↑, 1,   FOXP3↑, 1,   HLA-I/II↑, 1,   HMGB1↓, 2,   HMGB1↑, 2,   i-HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 1,   IL1↓, 1,   IL10↓, 2,   IL12↑, 1,   IL17↓, 1,   IL1β↓, 2,   IL2↑, 1,   IL4↓, 1,   IL6↓, 7,   IL8↓, 1,   Imm↑, 6,   Imm↝, 1,   Inflam↓, 8,   pol-M1↑, 1,   M2 MC↓, 1,   pol-M2 MC↓, 1,   MCP1/CCL2↓, 1,   MCT1↓, 1,   NF-kB↓, 22,   NF-kB↑, 2,   p‑NF-kB↓, 1,   NK cell↑, 3,   p65↓, 2,   PD-1↓, 2,   PD-L1↓, 5,   PGE2↓, 5,   PSA↓, 3,   T-Cell↑, 1,   TCF↓, 1,   TCF↝, 1,   Th1 response↑, 1,   TLR4↓, 2,   TNF-α↓, 5,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

e-pH↑, 1,   i-pH↓, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 3,   AR↑, 1,   ER-α36↓, 2,   PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 2,   BioAv↓, 9,   BioAv↑, 11,   BioAv↝, 7,   BioEnh↑, 1,   ChemoSen↓, 2,   ChemoSen↑, 45,   CYP1A1↑, 2,   CYP1A2↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 2,   Dose↓, 2,   Dose↑, 4,   Dose↝, 22,   Dose∅, 3,   eff↓, 24,   eff↑, 46,   eff↝, 6,   GSTZ1↓, 1,   Half-Life↓, 4,   Half-Life↝, 2,   MDR1↓, 2,   P-gp/ABCB1↓, 9,   P-gp/ABCB1↑, 1,   P450↓, 1,   RadioS↑, 12,   selectivity↑, 32,   selectivity∅, 1,   Synergy↑, 29,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   AR↓, 3,   AR↑, 1,   AST↓, 1,   BG↓, 2,   BloodF↑, 1,   BMD↑, 1,   CEA↓, 1,   CRP↓, 1,   EGFR↓, 9,   EGFR↑, 1,   EZH2↓, 1,   HER2/EBBR2↓, 5,   hTERT/TERT↓, 3,   IL6↓, 7,   LDH↓, 10,   LDH↑, 1,   p‑LDH↓, 1,   Myc↓, 1,   PD-L1↓, 5,   PSA↓, 3,   TG/TAG↓, 1,   TP53↓, 2,   TP53↑, 1,   TRIB3↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 15,   AntiTum↑, 6,   cardioP↑, 2,   chemoP↑, 6,   chemoPv↑, 1,   ChemoSideEff↓, 2,   fatigue↓, 1,   hepatoP↑, 2,   hepatoP∅, 1,   neuroP↑, 2,   NP/CIPN↓, 3,   OS↑, 6,   PFS↑, 1,   QoL↑, 2,   radioP↑, 1,   RenoP↑, 1,   Risk↓, 4,   toxicity↓, 10,   toxicity↑, 1,   toxicity↝, 5,   toxicity∅, 2,   TumVol↓, 6,   TumW↓, 3,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiP↑, 1,   GutMicro↑, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 681

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 35,   ARE↑, 2,   Catalase↑, 20,   GPx↑, 17,   GPx1↑, 1,   GPx4↑, 1,   GSH↓, 1,   GSH↑, 18,   GSR↓, 1,   GSR↑, 1,   GSTs↑, 3,   H2O2↓, 3,   HO-1↓, 1,   HO-1↑, 14,   Iron↓, 1,   Keap1↓, 2,   Keap1↑, 1,   Keap1↝, 1,   lipid-P↓, 20,   mt-lipid-P↓, 1,   MDA↓, 11,   MDA↑, 1,   MPO↓, 3,   NADPH/NADP+↑, 1,   NQO1↑, 4,   Nrf1↑, 1,   NRF2?, 1,   NRF2↑, 25,   Prx↓, 1,   Prx↑, 1,   ROS↓, 57,   ROS↑, 5,   ROS∅, 1,   mt-ROS?, 1,   mt-ROS↓, 1,   mt-ROS↑, 1,   SAM-e↑, 1,   SOD↑, 21,   SOD1↑, 2,   SOD2↑, 2,   TAC↑, 1,   TBARS↓, 1,   Trx↑, 1,   uricA↓, 1,   VitC↑, 2,   VitE↑, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,   Mets↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↓, 1,   compI↑, 3,   compII↑, 2,   compIII↓, 1,   compIII↑, 3,   compIV↑, 3,   DRP1/DNM1L↓, 2,   DRP1/DNM1L↑, 1,   p‑DRP1/DNM1L↝, 1,   ETC↓, 1,   ETC↑, 4,   FIS1↓, 3,   FIS1↑, 1,   Insulin↑, 1,   MFN1↑, 1,   MFN1↝, 1,   MFN2↓, 1,   MFN2↑, 4,   MFN2↝, 1,   mitResp↑, 6,   mtDam↓, 4,   OCR↑, 3,   mt-OCR↑, 1,   OPA1↓, 1,   OPA1↑, 2,   OXPHOS↑, 5,   PGC-1α↑, 10,   PGC-1α↝, 1,   PINK1↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   mt-ACC⇅, 1,   Acetyl-CoA↑, 1,   ALAT↓, 7,   AMPK↓, 2,   AMPK↑, 8,   ATP↓, 6,   ATP↑, 62,   ATP↝, 1,   ATP∅, 1,   mt-ATP↑, 1,   ECAR↑, 1,   ECAR∅, 1,   FAO↑, 3,   FASN↓, 1,   G6PD↑, 1,   glucoNG↓, 1,   glucose↓, 3,   glucose↝, 3,   GlucoseCon↓, 1,   GlucoseCon↑, 5,   Glycolysis↓, 2,   Glycolysis↑, 2,   Glycolysis↝, 2,   GSK‐3β↓, 4,   GSK‐3β↑, 2,   HK2↓, 2,   KeyT↝, 1,   lactateProd↓, 2,   LDHA↓, 1,   LDHB↑, 1,   LDL↓, 2,   NAD↓, 1,   NAD↑, 1,   NAD↝, 1,   NADH:NAD↑, 1,   NADPH↓, 3,   NADPH↑, 3,   NH3↑, 1,   PDKs↑, 1,   PFK↓, 2,   PFK2↓, 1,   PGM1?, 1,   PKM1↑, 1,   PKM2↓, 1,   PKM2↑, 1,   PPP↓, 1,   SCFAs↑, 1,   SIRT1↑, 5,   SREBP1/SREBF1↑, 1,   TCA↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 2,   Apoptosis↓, 9,   BAX↓, 2,   BAX↑, 2,   Bax:Bcl2↓, 1,   Bcl-2↓, 3,   Bcl-2↑, 4,   Casp↓, 1,   Casp12↓, 1,   Casp3↓, 10,   Casp3↑, 3,   Casp9↓, 4,   Casp9↑, 2,   Cyt‑c↓, 3,   Cyt‑c∅, 1,   Ferroptosis↓, 2,   GranB/GZMB↓, 1,   GSDMD↓, 1,   iNOS↓, 8,   p38↓, 2,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   Akt↑, 4,   CREB↑, 1,   ERK↓, 1,   Hippo↑, 1,   JAK2↑, 1,   p‑JNK↓, 2,   MAPK↓, 4,   mTOR↓, 3,   mTOR↑, 1,   p‑mTOR↑, 1,   PI3K↓, 3,   PI3K↑, 3,   PKA↑, 1,   PP2A↑, 1,   RAS↓, 1,   STAT↓, 1,   STAT3↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↑, 1,   ATF4↓, 2,   FOXO↑, 1,   FOXO3↑, 2,   HDAC2↓, 1,   miR-34a↓, 1,   other?, 1,   other↑, 5,   other↝, 6,   SOX2↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 3,   p‑eIF2α↓, 1,   ER Stress↓, 2,   GRP78/BiP↓, 2,   GRP78/BiP↑, 1,   HSP70/HSPA5↝, 1,   UPR↑, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↓, 1,   LC3II↑, 2,   MitoP↑, 3,   p62↓, 1,   p62↑, 3,   PARK2↑, 2,  

DNA Damage & Repair(tgid=10) ⓘ

P53↓, 1,   PARP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

GADD34↓, 1,   Ki-67↑, 1,   P21↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMPs↑, 1,   Diff↑, 1,   HH↓, 1,   Ki-67↑, 1,   Nestin↑, 1,   neuroG↑, 2,   NOTCH1↑, 1,   TumCP↓, 1,   Wnt↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 2,   Ca+2↓, 3,   Ca+2↑, 3,   Ca+2↝, 2,   Cartilage↑, 1,   FAK↑, 1,   MMP13↓, 1,   MMP9↓, 1,   serineP↓, 1,   SMAD3↓, 1,   p‑T-cadherin↓, 1,   TGF-β↓, 2,   TGF-β↑, 1,   TIMP1↓, 1,   Vim↓, 1,   α-SMA↓, 1,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 1,   E-sel↓, 1,   eNOS↑, 1,   Hif1a↓, 1,   NO↓, 3,   NO↑, 1,   VCAM-1↓, 2,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 9,   BBB↝, 1,   GastroP↑, 2,   GLUT4↑, 1,   H+/K+-ATPase↓, 1,   IBI↑, 1,   memfluid↑, 1,   MMP↓, 4,   MMP↑, 15,   MUC5AC↓, 1,   TRPV3↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   CD4+↑, 2,   CD8+↑, 1,   COX2/PTGS2↓, 7,   COX2/PTGS2↑, 1,   HMGB1↓, 1,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL10↓, 3,   IL10↑, 1,   IL17↓, 3,   IL18↓, 1,   IL1β↓, 15,   IL2↓, 2,   IL33↓, 1,   IL4↓, 2,   IL6↓, 16,   IL6↑, 1,   IL8↓, 4,   Imm↓, 1,   Imm↑, 3,   INF-γ↓, 1,   Inflam↓, 44,   LPS↓, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 1,   NeuroI↓, 1,   NF-kB↓, 14,   NF-kB↑, 1,   p‑NF-kB↓, 1,   NK cell↑, 1,   NLRP3↓, 3,   p65↓, 1,   PGE2↓, 3,   TLR4↓, 1,   TNF-α↓, 22,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 2,   Ach↑, 3,   AChE↓, 9,   BChE↓, 2,   BDNF↓, 1,   BDNF↑, 5,   ChAT↑, 2,   DA↑, 1,   MAOA↓, 2,   MAOB↓, 1,   NGF↑, 2,   TrkB↑, 2,  

Protein Aggregation(tgid=19) ⓘ

APP↓, 5,   Aβ↓, 21,   Aβ42↓, 1,   BACE/β-secretase↓, 8,   tau↓, 2,   p‑tau↓, 8,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ACE/ACE1↑, 1,   ACE2↓, 1,   ER(estro)↓, 1,   FGF21↑, 1,   PPARα↑, 2,   PPARγ↑, 3,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 5,   BioAv↑, 13,   BioAv↝, 8,   BioEnh↑, 1,   Dose↑, 1,   Dose↝, 12,   eff↓, 4,   eff↑, 9,   eff↝, 1,   Half-Life↓, 1,   Half-Life↝, 4,   P450↑, 1,   selectivity↑, 2,   Synergy↑, 9,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 7,   AST↓, 7,   BG↓, 1,   BloodF↑, 5,   BMD↑, 3,   BP↓, 2,   BP↝, 1,   BP∅, 1,   BUN↓, 1,   Calcium↑, 1,   creat↓, 3,   CRP↓, 3,   Hcy/homoC↓, 1,   hs-CRP↓, 1,   IL6↓, 16,   IL6↑, 1,   IRes↝, 1,   KeyT↝, 1,   LDH↓, 2,   Mag↑, 1,   NOS2↓, 2,   TC↓, 1,   TG/TAG↓, 1,   Urea↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 4,   antiAll↑, 6,   AntiArt↑, 2,   AntiCan↑, 3,   AntiDiabetic↑, 8,   antiPs↑, 2,   AntiTum↑, 1,   Bone Healing↑, 1,   cardioP↑, 14,   CardioT↓, 1,   chemoP↑, 3,   chemoPv↑, 3,   ChemoSideEff↓, 1,   cognitive↑, 23,   diuretic↑, 1,   hepatoP↓, 1,   hepatoP↑, 19,   Learn↑, 1,   memory↑, 15,   Mood↑, 1,   motorD↓, 1,   motorD↑, 6,   neuroP↑, 38,   Obesity↓, 6,   Pain↓, 2,   radioP↑, 1,   RenoP↑, 6,   Risk↓, 3,   Strength↑, 1,   Stress↓, 1,   Stroke↓, 6,   toxicity↓, 11,   toxicity↑, 2,   toxicity↝, 7,   toxicity∅, 3,   Weight↓, 1,   Wound Healing↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 4,   AntiFungal↑, 2,   AntiP↑, 2,   AntiViral↑, 5,   Bacteria↓, 7,   Diar↓, 1,   GutMicro↑, 7,   Sepsis↓, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 1,  
Total Targets: 398

Scientific Paper Hit Count for: ATP, Adenosine triphosphate
11 3-bromopyruvate
9 Magnetic Fields
9 Vitamin C (Ascorbic Acid)
6 Silver-NanoParticles
6 Berberine
6 Citric Acid
6 Ivermectin
6 Resveratrol
6 Shikonin
5 Alpha-Lipoic-Acid
5 Graviola
5 Melatonin
5 Quercetin
5 salinomycin
4 Ashwagandha(Withaferin A)
4 Capsaicin
4 Curcumin
4 EGCG (Epigallocatechin Gallate)
4 Emodin
4 Hydrogen Gas
4 Luteolin
4 Metformin
4 Urolithin
3 2-DeoxyGlucose
3 Radiotherapy/Radiation
3 Apigenin (mainly Parsley)
3 Propolis -bee glue
3 immunotherapy
3 Crocetin
3 Copper and Cu NanoParticles
3 diet FMD Fasting Mimicking Diet
3 Honokiol
3 Isoliquiritigenin
3 Kaempferol
3 Licochalcone A
3 Linalool
3 Methylene blue
3 Rosmarinic acid
3 Sulforaphane (mainly Broccoli)
3 Silymarin (Milk Thistle) silibinin
3 Ursolic acid
2 Allicin (mainly Garlic)
2 DTS(dibenzyl trisulphide) from Anamu
2 chaetocin
2 Chrysin
2 Citicoline, CDP-Choline
2 Cucurbitacin
2 Diclofenac
2 Docosahexaenoic Acid
2 Chemotherapy
2 Ginkgo biloba-EGb 761
2 Formononetin
2 Galloflavin
2 Ginkgo biloba
2 Gossypol/AT-101
2 Cisplatin
2 Isovitexin
2 Matrine
2 Methylglyoxal
2 Pachymic acid
2 Phenethyl isothiocyanate
2 Thymoquinone
2 Vitamin B5,Pantothenic Acid
2 Vitamin K2
1 Sorafenib (brand name Nexavar)
1 cetuximab
1 Anthocyanins
1 Auranofin
1 Acetyl-l-carnitine
1 Andrographis
1 doxorubicin
1 Artemisinin
1 Aloe anthraquinones
1 Betulinic acid
1 Brutieridin–Melitidin Mixture
1 Boron
1 Boswellia (frankincense)
1 α-Bisabolol / Chamomile oil
1 Bullatacin
1 Carvacrol
1 Cannabidiol
1 Celecoxib
1 Centella asiatica / Gotu kola → asiaticoside
1 Chlorogenic acid
1 Cichoric acid / Chicoric acid
1 Chlorella (Chlorella vulgaris)
1 Spirulina(Arthrospira/Limnospira)
1 Dichloroacetate
1 Diindolylmethane
1 Disulfiram
1 Electrical Pulses
1 Ferulic acid
1 Ginseng
1 hydrogen sulfide
1 Hyperthermia
1 Isobavachalcone
1 Inositol
1 isoquercitrin
1 itraconazole
1 Lapachol
1 Lasiodin
1 Lycopene
1 MCT oil
1 Methyl Jasmonate
1 Magnetic Field Rotating
1 Magnesium
1 Moringa oleifera
1 Morin
1 Mushroom Chaga, Inonotus obliquus
1 Pterostilbene
1 Radio Frequency
1 EMF
1 SonoDynamic Therapy UltraSound
1 triptolide
1 Vitamin B1/Thiamine
1 Vitamin B12
1 Folic Acid, Vit B9
1 Vitamin B2,Riboflavin
1 Arsenic trioxide
1 probiotics
1 Vitexin
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:21  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page